| Autor: |
Medina, E. A. Gracia, Caballero, A. Ning, Caballero, B. Benitez, Avila, D. R. Martinez, Madruga, T. González, Galainena, J. Jiménez, Pérez, D. Sánchez, Estévez, D. Alfonso, Benet, R. Y. Ortiz, Cabello, J. R. Mestre, Fernández, N. González, Olazabal, E. Vásquez |
| Předmět: |
|
| Zdroj: |
Hematological Oncology; Jun2023 Supplement S2, Vol. 41, p700-700, 1p |
| Abstrakt: |
In conclusion, diffuse large B-Cell lymphoma found to have the higher incidence, combined treatment of CT+IFRT was the most prescribe treatment. Most of the patients were diagnosed in localized stages 73.2% (24 stage I, 42 stage II) Diffuse large B-Cell Lymphomas was the most common histologic subtype (65 patients, 67.0%), followed by peripheral T-cell lymphoma (8 patients, 8.2%) and mantle cell lymphoma (8 patients, 8.2%). Combined treatment of chemotherapy (CT) ± rituximab with involved field radiotherapy (IFRT) was the main therapeutic approach (51.2%), followed by CT ± rituximab in 40.1% of cases. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text